Early seed or late stage public financing. Large markets or rare diseases.
Established targets or novel technologies.
We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories.
Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation.